What value do norepinephrine/dopamine dual reuptake inhibitors have to the current treatment of adult attention deficit hyperactivity disorder (ADHD) treatment armamentarium?

Expert Opin Pharmacother. 2022 Dec;23(18):1975-1978. doi: 10.1080/14656566.2022.2148830. Epub 2022 Nov 16.
No abstract available

Keywords: ADHD; amphetamines; bupropion; methylphenidate.

Publication types

  • Editorial

MeSH terms

  • Adult
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Dopamine / therapeutic use
  • Dopamine Uptake Inhibitors
  • Humans
  • Norepinephrine* / therapeutic use

Substances

  • Norepinephrine
  • Dopamine
  • Dopamine Uptake Inhibitors